+1-786-628-7980
Sign Up/Sign In 
Findings from Facts and Factors report “Drug Delivery in Cancer Market By Product (Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and Others), by Application (Hospitals & Clinic, Cancer Treatment Centers, and Others) and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global drug delivery in cancer market in 2019 was approximately USD 1400.1 Million. The market is expected to grow at a CAGR of 7.1 % and is anticipated to reach around USD 2262.8 Million by 2026.
Increasing prevalence of the caner across the globe is major factor driving growth of the global drug delivery in cancer market. Additionally, increasing research and development in the field of cancer research is another factor to propel growth of the target market in the near future. Moreover, increasing old age population is another factor expected to fuel growth of the target market in the near future. Growing collaborations between the pharmaceutical companies worldwide is expected to boost growth of the target market in the near future. However, high costs associated with the research and development is key factor to restrain growth of the target market in the near future.
The drug delivery in cancer market is segmented based on type, application, and geography. On the basis of type the target market can be segmented as Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and Others. Based on application segment the global market can be divided into hospitals & clinic, cancer treatment centers, and others. On the basis of application segment the cancer treatment centers are expected to register significant CAGR over the forecast year in the target market.
Get free Sample of this Research Report – https://www.fnfresearch.com/sample/drug-delivery-in-cancer-market-by-product-liposomes-1157
Based upon the region the global market has been categorized as North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. North America is expected to dominate in the global market in terms of revenue as compared to that of markets in other regions during the forecast period 2019-2026. This is attributed to the availability of advanced healthcare sector in the countries of this region along with growing need for drug delivery in cancer in this region. Growing government funding for research is supporting the growth of the market in the region. Europe is expected to hold the second-largest share and Asia Pacific is anticipated to grow at significant CAGR in the near future. Europe market growth is owing to increasing number of discovery initiatives by pharmaceutical companies in the Europe especially in the U.K. and in the Germany of the region. The growth in the Asia Pacific countries is presence of a favorable business environment in the countries of the Asia Pacific.
Key players operating in the drug delivery in cancer market not restricted to include Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson, Takeda, and Gilead Sciences. Major companies in the global drug delivery in cancer market are focusing on the launches of innovative products to get competitive edge in the target market.
This report segments the drug delivery in cancer market as follows:
Global Drug Delivery in Cancer Market: Type
Global Drug Delivery in Cancer Market: Application
Global Drug Delivery in Cancer Market: Regional Segmentation Analysis
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
